147 related articles for article (PubMed ID: 31607147)
1. Mechanisms of the Multitasking Endothelial Protein NRG-1 as a Compensatory Factor During Chronic Heart Failure.
De Keulenaer GW; Feyen E; Dugaucquier L; Shakeri H; Shchendrygina A; Belenkov YN; Brink M; Vermeulen Z; Segers VFM
Circ Heart Fail; 2019 Oct; 12(10):e006288. PubMed ID: 31607147
[TBL] [Abstract][Full Text] [Related]
2. Neuregulin as a heart failure therapy and mediator of reverse remodeling.
Galindo CL; Ryzhov S; Sawyer DB
Curr Heart Fail Rep; 2014 Mar; 11(1):40-9. PubMed ID: 24234399
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory actions of the NRG-1/ErbB4 pathway in macrophages during tissue fibrosis in the heart, skin, and lung.
Vermeulen Z; Hervent AS; Dugaucquier L; Vandekerckhove L; Rombouts M; Beyens M; Schrijvers DM; De Meyer GRY; Maudsley S; De Keulenaer GW; Segers VFM
Am J Physiol Heart Circ Physiol; 2017 Nov; 313(5):H934-H945. PubMed ID: 28822966
[TBL] [Abstract][Full Text] [Related]
4. Neuregulin-1/ErbB signaling and chronic heart failure.
Xu Y; Li X; Liu X; Zhou M
Adv Pharmacol; 2010; 59():31-51. PubMed ID: 20933198
[TBL] [Abstract][Full Text] [Related]
5. Neuregulin-1 and its potential role in the control of cardiac function.
Lemmens K; Doggen K; Keulenaer GW
Heart Fail Monit; 2008 Feb; 5(4):119-24. PubMed ID: 18273495
[TBL] [Abstract][Full Text] [Related]
6. Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt.
Fukazawa R; Miller TA; Kuramochi Y; Frantz S; Kim YD; Marchionni MA; Kelly RA; Sawyer DB
J Mol Cell Cardiol; 2003 Dec; 35(12):1473-9. PubMed ID: 14654373
[TBL] [Abstract][Full Text] [Related]
7. Qiliqiangxin protects against anoxic injury in cardiac microvascular endothelial cells via NRG-1/ErbB-PI3K/Akt/mTOR pathway.
Wang J; Zhou J; Wang Y; Yang C; Fu M; Zhang J; Han X; Li Z; Hu K; Ge J
J Cell Mol Med; 2017 Sep; 21(9):1905-1914. PubMed ID: 28271613
[TBL] [Abstract][Full Text] [Related]
8. Ventricular ErbB2/ErbB4 activation and downstream signaling in pacing-induced heart failure.
Doggen K; Ray L; Mathieu M; Mc Entee K; Lemmens K; De Keulenaer GW
J Mol Cell Cardiol; 2009 Jan; 46(1):33-8. PubMed ID: 19010331
[TBL] [Abstract][Full Text] [Related]
9. Constitutive activation of the neuregulin-1/erbB signaling pathway promotes the proliferation of a human peripheral neuroepithelioma cell line.
Fallon KB; Havlioglu N; Hamilton LH; Cheng TP; Carroll SL
J Neurooncol; 2004 Feb; 66(3):273-84. PubMed ID: 15015657
[TBL] [Abstract][Full Text] [Related]
10. Neuregulin in cardiovascular development and disease.
Odiete O; Hill MF; Sawyer DB
Circ Res; 2012 Oct; 111(10):1376-85. PubMed ID: 23104879
[TBL] [Abstract][Full Text] [Related]
11. Central neuregulin-1/ErbB signaling modulates cardiac function via sympathetic activity in pressure overload-induced heart failure.
Matsukawa R; Hirooka Y; Ito K; Honda N; Sunagawa K
J Hypertens; 2014 Apr; 32(4):817-25. PubMed ID: 24406781
[TBL] [Abstract][Full Text] [Related]
12. [Establishment of an ErbB3- and ErbB4-specific ligand screening system, and a screen of neuregulin-1 mutants].
Qi Y; Wei DZ; Liu XF; Zhou MD
Yi Chuan; 2010 Dec; 32(12):1247-55. PubMed ID: 21513150
[TBL] [Abstract][Full Text] [Related]
13. Role of neuregulin-1/ErbB2 signaling in endothelium-cardiomyocyte cross-talk.
Lemmens K; Segers VF; Demolder M; De Keulenaer GW
J Biol Chem; 2006 Jul; 281(28):19469-77. PubMed ID: 16698793
[TBL] [Abstract][Full Text] [Related]
14. Neuregulin signaling and heart failure.
Jiang Z; Zhou M
Curr Heart Fail Rep; 2010 Mar; 7(1):42-7. PubMed ID: 20425496
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of neuregulin-1 in cardiovascular disease.
Mendes-Ferreira P; De Keulenaer GW; Leite-Moreira AF; Brás-Silva C
Drug Discov Today; 2013 Sep; 18(17-18):836-42. PubMed ID: 23384772
[TBL] [Abstract][Full Text] [Related]
16. Constitutive activation of the neuregulin-1/ErbB receptor signaling pathway is essential for the proliferation of a neoplastic Schwann cell line.
Frohnert PW; Stonecypher MS; Carroll SL
Glia; 2003 Aug; 43(2):104-18. PubMed ID: 12838503
[TBL] [Abstract][Full Text] [Related]
17. Neuregulin-1β induces proliferation, survival and paracrine signaling in normal human cardiac ventricular fibroblasts.
Kirabo A; Ryzhov S; Gupte M; Sengsayadeth S; Gumina RJ; Sawyer DB; Galindo CL
J Mol Cell Cardiol; 2017 Apr; 105():59-69. PubMed ID: 28263756
[TBL] [Abstract][Full Text] [Related]
18. Neuregulin receptors erbB2 and erbB4 in failing human myocardium -- depressed expression and attenuated activation.
Rohrbach S; Niemann B; Silber RE; Holtz J
Basic Res Cardiol; 2005 May; 100(3):240-9. PubMed ID: 15685397
[TBL] [Abstract][Full Text] [Related]
19. Chronic Neuregulin-1β Treatment Mitigates the Progression of Postmyocardial Infarction Heart Failure in the Setting of Type 1 Diabetes Mellitus by Suppressing Myocardial Apoptosis, Fibrosis, and Key Oxidant-Producing Enzymes.
Gupte M; Lal H; Ahmad F; Sawyer DB; Hill MF
J Card Fail; 2017 Dec; 23(12):887-899. PubMed ID: 28870731
[TBL] [Abstract][Full Text] [Related]
20. Neuregulin-1 signaling in the pathogenesis of chemotherapy-induced heart failure.
Lenneman CG
Curr Heart Fail Rep; 2014 Jun; 11(2):134-8. PubMed ID: 24682830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
